Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment
Lisa M Fucito1, Benjamin A Toll, Peter Salovey
1Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA. lisa.fucito@yale.edu
Abstract:
Beliefs about medication are associated with treatment adherence and outcome. This is a secondary analysis of the role of beliefs and attitudes about bupropion in treatment adherence and smoking cessation outcomes using data from a smoking cessation trial of open-label sustained-release (SR) bupropion therapy reported previously (Toll et al., 2007). Positive beliefs and attitudes were positively correlated with intentions, desire, confidence, and motivation to quit smoking; expectation of quitting success; perceived benefits of quitting; and perceived disadvantages of smoking. Positive beliefs were also associated with greater medication adherence, an increased likelihood of completing treatment and being continuously abstinent, and a delayed latency to smoking lapse. These findings provide preliminary support that positive beliefs and attitudes about bupropion are associated with positive attitudes toward quitting, better treatment adherence, and potentially better treatment response.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drug Dependence
Drug Therapy
Antianxiety Medications
Stress Prevention and Stress Management Techniques IV
Drug Abuse and Addiction: Pharmacological Phenomena
The Placebo Effect

